Your browser doesn't support javascript.
loading
Retrospective comparison of cabergoline and bromocriptine effects in hyperprolactinemia: a single center experience.
Arduc, A; Gokay, F; Isik, S; Ozuguz, U; Akbaba, G; Tutuncu, Y; Berker, D; Kucukler, F K; Aydin, Y; Guler, S.
Afiliación
  • Arduc A; National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Diabetes, Endocrine and Obesity Branch, Bethesda, MD, USA. ayse_arduc@yahoo.com.
  • Gokay F; , 1778 Dawson Street, Vienna, VA, 22182, USA. ayse_arduc@yahoo.com.
  • Isik S; Ministry Of Health, Endocrinology and Metabolism Clinic, Kayseri Research and Training Hospital, Kayseri, Turkey.
  • Ozuguz U; Ministry Of Health, Endocrinology and Metabolism Clinic, Ankara Numune Research and Training Hospital, Ankara, Turkey.
  • Akbaba G; Department of Endocrinology and Metabolism, Faculty of Medicine, Afyon Kocatepe University, Ankara, Turkey.
  • Tutuncu Y; Ministry Of Health, Endocrinology and Metabolism Clinic, Ankara Numune Research and Training Hospital, Ankara, Turkey.
  • Berker D; Ministry Of Health, Endocrinology and Metabolism Clinic, Ankara Numune Research and Training Hospital, Ankara, Turkey.
  • Kucukler FK; Ministry Of Health, Endocrinology and Metabolism Clinic, Ankara Numune Research and Training Hospital, Ankara, Turkey.
  • Aydin Y; Department of Endocrinology and Metabolism, Faculty of Medicine, Hitit University, Corum, Turkey.
  • Guler S; Department of Endocrinology and Metabolism, Duzce University Medical School, Duzce, Turkey.
J Endocrinol Invest ; 38(4): 447-53, 2015 Apr.
Article en En | MEDLINE | ID: mdl-25421155

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hiperprolactinemia / Bromocriptina / Agonistas de Dopamina / Ergolinas Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2015 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hiperprolactinemia / Bromocriptina / Agonistas de Dopamina / Ergolinas Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2015 Tipo del documento: Article